Julio C. Barredo - Concepedia

Author

Julio C. Barredo

Also Known As

J Barredo, J C Barredo, J. Barredo, J. C. Barredo, JULIO C. BARREDO, Jovel Barredo, Julio Barredo, Julio C Barredo, Julio C. Barredo

162

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Miami Medical University of South Carolina Sylvester Comprehensive Cancer Center The University of Texas Southwestern Medical Center St. Jude Children's Research Hospital

About

Julio C. Barredo is an author at University of Miami specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.7K
2	Natural Sciences	4	4	62
3	Health Sciences	3	3	222
4	Nursing	1	1	39
5	Public Health	1	1	39

Julio C. Barredo

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) Winfred C. Wang, Russell E. Ware, Scott T. Miller, The Lancet Baby HugPediatric EpidemiologyPediatric HematologySickle-cell AnaemiaHematology	2011	772
A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5yl)ethyl[benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthase Edward C. Taylor, Dietmar Kuhnt, Chuan Shih, Journal of Medicinal Chemistry	1992	252
Pleuropulmonary blastoma: A marker for familial disease John R. Priest, Jan Watterson, Louise C. Strong, The Journal of Pediatrics HistopathologyPleuropulmonary BlastomaPathologyPleural EffusionPleural Disease	1996	229
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Janet D. Rowley, Shalini C. Reshmi, Olatoyosi M. Sobulo, PubMed	1997	219
Differences in Folylpolyglutamate Synthetase and Dihydrofolate Reductase Expression in Human B-Lineage versus T-Lineage Leukemic Lymphoblasts: Mechanisms for Lineage Differences in Methotrexate Polyglutamylation and Cytotoxicity A J Galpin, John D. Schuetz, Eric Masson, Molecular Pharmacology	1997	117
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy Tapas K. Sengupta, Gilles M. Leclerc, Ting Ting Hsieh-Kinser, Molecular Cancer	2007	115
Isolated CNS Relapse of Acute Lymphoblastic Leukemia Treated With Intensive Systemic Chemotherapy and Delayed CNS Radiation: A Pediatric Oncology Group Study Julio C. Barredo, Meenakshi Devidas, Stephen J. Lauer, Journal of Clinical Oncology Intensive Systemic ChemotherapyIsolated Cns RelapseSurgical OncologyPurpose PrognosisCns Relapse	2006	114
Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts Gilles M. Leclerc, Guy J. Leclerc, Jeffim N. Kuznetsov, PLoS ONE ApoptosisImmunologyCell DeathCancer BiologyCell Death Mechanisms	2013	105
Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines Guy J. Leclerc, Gilles M. Leclerc, Julio C. Barredo Cancer Cell International	2002	100
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury Thomas V. Adamkiewicz, Miguel R. Abboud, Carole Paley, Blood	2009	92

Page 1